SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-031312
Filing Date
2023-02-10
Accepted
2023-02-10 07:26:02
Documents
13
Period of Report
2023-02-10
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d457412d8k.htm   iXBRL 8-K 29073
2 EX-99.1 d457412dex991.htm EX-99.1 10637
  Complete submission text file 0001193125-23-031312.txt   166574

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ortx-20230210.xsd EX-101.SCH 2530
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20230210_lab.xml EX-101.LAB 17897
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20230210_pre.xml EX-101.PRE 11277
7 EXTRACTED XBRL INSTANCE DOCUMENT d457412d8k_htm.xml XML 3592
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 23608551
SIC: 2836 Biological Products, (No Diagnostic Substances)